Literature DB >> 18313325

Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.

Gilberta Giacchetti1, Paolo Mulatero, Franco Mantero, Franco Veglio, Marco Boscaro, Francesco Fallo.   

Abstract

There is general consensus on the use of (but not cut-off values for) the aldosterone/plasma renin activity ratio as a screening test for primary aldosteronism. There is also agreement on the need for subsequent confirmatory testing, but not on the protocols to be chosen. The four most common confirmatory tests in clinical practice are oral sodium loading, intravenous saline infusion, captopril challenge and fludrocortisone administration plus sodium loading. The choice of test reflects multiple variables: patient factors (including accessibility, compliance and safety), established practice and cost. Finally, subtype forms and lateralization of aldosterone production should be established by bilateral adrenal venous sampling, despite its technical difficulty and varying criteria for success.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313325     DOI: 10.1016/j.tem.2008.01.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  7 in total

1.  Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division.

Authors:  Dan Ye; FengQin Dong; XunLiang Lu; Zhe Zhang; YunFei Feng; ChengJiang Li
Journal:  Endocrine       Date:  2012-01-03       Impact factor: 3.633

2.  Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression.

Authors:  Shreekrishna Maharjan; Brahmaraju Mopidevi; Meenakshi Kaul Kaw; Nitin Puri; Ashok Kumar
Journal:  Physiol Genomics       Date:  2014-10-28       Impact factor: 3.107

3.  Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands.

Authors:  Tao Wang; Fumitoshi Satoh; Ryo Morimoto; Yasuhiro Nakamura; Hironobu Sasano; Richard J Auchus; Michael A Edwards; William E Rainey
Journal:  Eur J Endocrinol       Date:  2011-01-19       Impact factor: 6.664

4.  Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism.

Authors:  Yi-Chun Chen; Yu-Chieh Su; Chang-Kuo Wei; Jainn-Shiun Chiu; Chih-En Tseng; Shao-Jer Chen; Yuh-Feng Wang
Journal:  J Biomed Biotechnol       Date:  2011-04-07

5.  Concurrent Primary Aldosteronism and Renal Artery Stenosis: An Overlooked Condition Inducing Resistant Hypertension.

Authors:  Lin Zhao; Jinhong Xue; Yi Zhou; Xueqi Dong; Fang Luo; Xiongjing Jiang; Xinping Du; Xianliang Zhou; Xu Meng
Journal:  Front Cardiovasc Med       Date:  2022-03-03

6.  NP-59 SPECT/CT imaging in stage 1 hypertensive and atypical primary aldosteronism: a 5-year retrospective analysis of clinicolaboratory and imaging features.

Authors:  Yi-Chun Chen; Jainn-Shiun Chiu; Yuh-Feng Wang
Journal:  ScientificWorldJournal       Date:  2013-10-21

Review 7.  New advances in the diagnosis of primary aldosteronism.

Authors:  Hang Shen; Zhi-Xin Xu; Qi-Fu Li
Journal:  Chronic Dis Transl Med       Date:  2020-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.